Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Please help!!! I own a very large independent community pharmacy that has been a fixture in my community for 58 years since my father started this business in 1959. The PBM's are using every unfair business tactic made available to them by their own discretion to steal customers away from me! By using the word steal, I mean that my customers want to come to my pharmacy, but are being 'steared' towards the pharmacy owned by the PBM's. PBMs are not the helpful, cost-savings third-party administrators they portray. They are industry middlemen profiting at every stage of the prescription drug supply chain from the manufacturers and the dispensers to the plan payers and patient. They are driving up drug prices, promoting the use of certain drugs over others, forcing medical providers to remain silent and costing patients and taxpayers tens of millions of dollars every year. The FTC's mission is to protect consumers and prevent anticompetitive business practices. On behalf of patients, drug plan sponsors and small business pharmacies who depend on trusting relationships with their patients, please intervene in these unregulated entities and break up the enormous power PBMs have over the out-of-control cost of healthcare.